Evidence map›Paper›PMID 36145357›Full record

ArticlePharmaceuticals (Basel, Switzerland)2022

Molecular Insight into

Igor Mokrousov, Ivaylo Slavchev, Natalia Solovieva, Marine Dogonadze, Anna Vyazovaya, Violeta Valcheva, Aleksey Masharsky, Olesya Belopolskaya, Simeon Dimitrov, Viacheslav Zhuravlev and 3 more

Open access · goldAbstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Genomic Insight into Primary Adaptation ofAntibiotics (Basel, Switzerland) · 2025
    Article
  2. Article
  3. Multidrug-resistant tuberculosis.Nature reviews. Disease primers · 2024
    Review
  4. International journal of microbiology · 2024
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 4 countries.

Igor MokrousovLaboratory of Molecular Epidemiology and Evolutionary Genetics, St. Petersburg Pasteur Institute, 197101 St. Petersburg, Russia.ORCID 0000-0001-5924-0576
Ivaylo SlavchevInstitute of Organic Chemistry with Centre of Phytochemistry, Acad. G. Bonchev Street, bl. 9, 1113 Sofia, Bulgaria.
Natalia SolovievaSt. Petersburg Research Institute of Phthisiopulmonology, 191036 St. Petersburg, Russia.
Marine DogonadzeSt. Petersburg Research Institute of Phthisiopulmonology, 191036 St. Petersburg, Russia.
Anna VyazovayaLaboratory of Molecular Epidemiology and Evolutionary Genetics, St. Petersburg Pasteur Institute, 197101 St. Petersburg, Russia.
Violeta ValchevaThe Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, Acad. G. Bonchev Street, bl. 26, 1113 Sofia, Bulgaria.
Aleksey MasharskyResource Center "Bio-bank Center", Research Park of St. Petersburg State University, 198504 St. Petersburg, Russia.
Olesya BelopolskayaResource Center "Bio-bank Center", Research Park of St. Petersburg State University, 198504 St. Petersburg, Russia.ORCID 0000-0003-2002-4192
Simeon DimitrovThe Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, Acad. G. Bonchev Street, bl. 26, 1113 Sofia, Bulgaria.
Viacheslav ZhuravlevSt. Petersburg Research Institute of Phthisiopulmonology, 191036 St. Petersburg, Russia.ORCID 0000-0001-6906-6225
Isabel PortugaliMed.ULisboa-Instituto de Investigação do Medicamento, Faculdade de Farmácia, Universidade de Lisboa, 1649004 Lisbon, Portugal.
João PerdigãoiMed.ULisboa-Instituto de Investigação do Medicamento, Faculdade de Farmácia, Universidade de Lisboa, 1649004 Lisbon, Portugal.
Georgi M DobrikovInstitute of Organic Chemistry with Centre of Phytochemistry, Acad. G. Bonchev Street, bl. 9, 1113 Sofia, Bulgaria.ORCID 0000-0003-0437-2162
Saint-Petersburg Research Institute of Phthisiopulmonology · RUBulgarian Academy of Sciences · BGInstitute of Organic Chemistry with Centre of Phytochemistry · BGUniversity of Lisbon · PTSaint Petersburg Pasteur Institute · RUZhengzhou University · CN

Funding

Bulgarian Science Fund KP-06-N39/7Bulgarian Science Fund KP-06-N41/3Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing АААА-А21-121021600206-5Fundação para a Ciência e Tecnologia CEECIND/00394/2017Fundação para a Ciência e Tecnologia UID/DTP/04138/2019Russian Science Foundation 19-15-00028
6 · The paper itself

Abstract

We performed synthesis of new nitrofuranyl amides and investigated their anti-TB activity and primary genetic response of mycobacteria through whole-genome sequencing (WGS) of spontaneous resistant mutants. The in vitro activity was assessed on reference strain

Indexed as

mycobacterium tuberculosisnitrofuranyl amidesspontaneous mutagenesiswhole-genome sequencing

Identifiers

PMID36145357
PMCPMC9504009
OpenAlexW4296005568

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.